# Cell-type specificity of Tim-3 in respiratory diseases: from mechanisms to clinical translation

**Authors:** Qi Cui, Jinying Dou, Fukun Wang, Keran Jia

PMC · DOI: 10.3389/fimmu.2026.1770761 · 2026-03-05

## TL;DR

This paper explores how Tim-3, an immune molecule, functions in different respiratory diseases and its potential for treatment.

## Contribution

The paper highlights the dual role of Tim-3 in respiratory diseases and its potential as a biomarker and immunotherapy target.

## Key findings

- Tim-3 is crucial for immune homeostasis and inflammation control in respiratory diseases.
- Tim-3 has both protective and pathogenic roles in conditions like asthma and COPD.
- Tim-3 is being considered as a potential biomarker and immunotherapy target.

## Abstract

As an immune checkpoint molecule, Tim-3 is expressed on T cells and other immune cells, and is crucial for maintaining immune homeostasis and preventing excessive inflammation. This article reviews the changes in expression, mechanism of action, and clinical significance of Tim-3 in major respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), pulmonary infections, lung cancer, and pulmonary fibrosis. It emphasizes the dual role (protective and pathogenic) of Tim-3 in respiratory diseases and prospects its potential as a disease biomarker and a new target for immunotherapy.

## Linked entities

- **Proteins:** HAVCR2 (hepatitis A virus cellular receptor 2)
- **Diseases:** asthma (MONDO:0004979), chronic obstructive pulmonary disease (MONDO:0005002), acute respiratory distress syndrome (MONDO:0006502), lung cancer (MONDO:0005138), pulmonary fibrosis (MONDO:0002771)

## Full-text entities

- **Genes:** HAVCR2 (hepatitis A virus cellular receptor 2) [NCBI Gene 84868] {aka CD366, HAVcr-2, KIM-3, SPTCL, TIM3, TIMD-3}
- **Diseases:** respiratory diseases (MESH:D012140), asthma (MESH:D001249), inflammation (MESH:D007249), pulmonary fibrosis (MESH:D011658), COPD (MESH:D029424), ARDS (MESH:D012128), pulmonary infections (MESH:D012141), lung cancer (MESH:D008175)

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12999843/full.md

---
Source: https://tomesphere.com/paper/PMC12999843